Patients undergoing prophylactic central compartment dissection (PCLND) for papillary thyroid cancer (PTC) are often overtreated. This study aimed to determine if molecular fluorescence-guided imaging (MFGI) and spectroscopy can be useful for detecting PTC nodal metastases (NM) and to identify negative central compartments intraoperatively.
Conclusion: Visualization of c-MET expression with 68Ga-EMP-100 PET imaging allows for clinicopathological staging in mRCC and has potential as a predictive biomarker of targeted therapies.
https://link.springer.com/article/10.1007/s00259-022-05763-3
![259_2022_5763_Fig3_HTML](https://emimaging.com/wp-content/uploads/2022/04/259_2022_5763_Fig3_HTML.webp)